Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Oncogene|June 26, 2002
p53 mutations and tetraploids under r- and K-selectionNorio Chikatsu, Yukari Nakamura, Hiroyuki Sato, et al.Clinical Chemistry|February 23, 2008
Ex vivo simulation of the action of antileukemia drugs by measuring apoptosis-related mRNA in bloodMasato Mitsuhashi, Katsuya Endo, Kazuhiko Obara, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 1, 2010
[Prediction of treatment efficacy by the M-protein reduction rate after the first cycle of VAD therapy for multiple myeloma]Yuriko Momma, Atsushi Shinagawa, Takayuki Katsura, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 16, 2003
ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC)Norio Chikatsu, Hiroshi Kojima, Kazumi Suzukawa, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 23, 2011
[Reported use of thalidomide in multiple myeloma: presentation of problems in the Thaled® outpatient department]Yuka Aimono, Wataru Sato, Eriko Otani, et al.International Journal of Hematology|April 28, 2011
Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemiaChikashi Yoshida, Takuya Komeno, Mitsuo Hori, et al.Pageof 1